Literature DB >> 3729932

The nuclear matrix is the site of glucocorticoid receptor complex action in the nucleus.

T M Kirsch, A Miller-Diener, G Litwack.   

Abstract

Binding of highly purified glucocorticoid receptor complexes to nuclear matrix was evaluated. Extraction of purified nuclei with 2M potassium chloride and brief deoxyribonuclease digestion leaves a matrix structure containing 1% of nuclear DNA and 6-12% of nuclear proteins. The nuclear matrix retained two binding sites for receptor complexes, a high affinity, low capacity site and a low affinity, high capacity site. These sites have affinities and capacities consistent with those reported for binding of these complexes to intact nuclei. More extensive deoxyribonuclease treatment of the matrix resulted in a marked reduction of high affinity complex binding. Furthermore, the DNA binding form of the receptor complex but not the unactivated receptor complex bound to DNA fibers anchored to nuclear matrix as visualized by 18 nm gold particle receptor complexes. The data suggest that the nuclear matrix is the major site for coordinating glucocorticoid hormone action in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729932     DOI: 10.1016/0006-291x(86)91126-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Purification of a nuclear protein (receptor binding factor-1) associated with the chromatin acceptor sites for the avian oviduct progesterone receptor.

Authors:  J Rejman; J Landers; A Goldberger; D J McCormick; B Gosse; T C Spelsberg
Journal:  J Protein Chem       Date:  1991-12

Review 2.  Rethinking cell structure.

Authors:  S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

3.  Localization of nuclear matrix proteins (NMPs) in multiple tissue types with NM-200.4 (an antibody strongly reactive with NMPs found in breast carcinoma).

Authors:  N Weidner; D S Weinberg; S C Hardy; K A Hollister; G P Lidgard
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.